Can-Fite BioPharma Ltd. Adjustments For Share-based Payments
Can-Fite BioPharma Ltd. (CANF) reported Adjustments For Share-based Payments of $385.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2020-03-27.
Discontinued › Notes › Compensation Related Costs
ifrs-full:AdjustmentsForSharebasedPayments · last filed 2020-03-27
| Period end | Adjustments For Share-based Payments 1 month | Adjustments For Share-based Payments 6 month | Adjustments For Share-based Payments 12 month | Adjustments For Share-based Payments 12 month as first filed |
|---|---|---|---|---|
| 2019-12-31 | $385.00K 20-F · filed 2020-03-27 | |||
| 2019-06-30 | $151.00K 6-K · filed 2019-08-30 | |||
| 2018-12-31 | $535.00K 20-F · filed 2020-03-27 | |||
| 2018-06-30 | $424.00K 6-K · filed 2019-08-30 | |||
| 2017-12-31 | $192.00K 20-F · filed 2020-03-27 | $196.00K 20-F · filed 2018-03-28 | ||
| 2017-06-30 | $95.00K 6-K · filed 2018-08-31 | |||
| 2016-12-31 | $322.00K 20-F · filed 2019-03-29 | |||
| 2016-05-31 | $74.00K 6-K · filed 2018-08-08 | |||
| 2015-12-31 | $109.00K 6-K · filed 2018-08-08 |